Florida News Releases | sciencenewsnet.in

Breaking News

Market Study Sheds Light on How Inclusive Shopping Experiences Make All Consumers Feel Valued

For People Living with HIV/AIDS, TB is Still the Leading Cause of Death

A Career of Chasing Particle Beams

Fowl play: Why the hunt for Thanksgiving’s favorite bird could get tougher

AI Safety Institute Launched as Korea’s AI Research Hub

No ‘one size fits all’ treatment for Type 1 Diabetes, study finds

Chula Lecturer Wins Creative Excellence Award 2024 for “Decorative Toys for the Elderly”

Improved Spin and Density Correlation Simulations Give Researchers Clearer Insights on Neutron Stars

American Thyroid Association® Recognizes 2024 Van Meter Award Winner

Breakthrough in Hazardous Gas Detection: New Technology Enhances Miniaturization and Accuracy

27 Nov, 2024

Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma

May 12, 2022 sarah JonasResearch Results

A study published by researchers from Mayo Clinic Cancer Center at Mayo Clinic in Florida and Case Western, Cleveland Medical Center, investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma treated with chimeric antigen receptor-T cell therapy (CAR-T cell therapy).